C. Ganellin

发表

Histamine H1‐Receptor in Heart: Unique Electrophoretic Mobility and Autoradiographic Localization

M. Bouthenet, M. Ruat, J. Schwartz, 1990, Journal of neurochemistry.

Compounds that block both intermediate‐conductance (IKCa) and small‐conductance (SKCa) calcium‐activated potassium channels

D. Jenkinson, D. Galanakis, C. Ganellin, 2000, British journal of pharmacology.

BF2.649 Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H 3 Receptor: Preclinical Pharmacology

H. Stark, J. Arrang, F. Gbahou, 2006 .

Design of an Affinity Matrix for Purification of the Histamine H1 Receptor from Guinea Pig Cerebellum

J. Schwartz, M. Garbarg, M. Ruat, 1992, Journal of neurochemistry.

Distinct pharmacology of rat and human histamine H3 receptors: role of two amino acids in the third transmembrane domain

C R Ganellin, J. Schwartz, H. Stark, 2000, British journal of pharmacology.

ANTIHISTAMINIC DIFFERENCES BETWEEN THE ENANTIOMERS OF DIMETHINDENE

A. Casy, C. Ganellin, A. Mercer, 1990 .

Zolantidine (SK&F 95282) is a potent selective brain‐penetrating histamine H2‐receptor antagonist

R. C. Young, R. Mitchell, C. Ganellin, 1988, British journal of pharmacology.

The tautomer ratio of histamine

C. Ganellin, 1973, The Journal of pharmacy and pharmacology.

Clotrimazole analogues: effective blockers of the slow afterhyperpolarization in cultured rat hippocampal pyramidal neurones

M. Shah, C. Ganellin, D. Haylett, 2001, British journal of pharmacology.

Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors

W. Duncan, G. J. Durant, C. Ganellin, 1978, Nature.

On the Concept of a Bivalent Pharmacophore for SKCa Channel Blockers: Synthesis, Pharmacological Testing, and Radioligand Binding Studies on Mono‐, Bis‐, and Tris‐quinolinium Compounds

D. Jenkinson, C. Ganellin, D. Galanakis, 1996, Archiv der Pharmazie.

Isocytosine H2-receptor histamine antagonists. IV. The synthesis and biological activity of donetidine (SK&F 93574) and related compounds

M. Parsons, T. Brown, G. Durant, 1993 .

The sleep lipid oleamide may represent an endogenous anticonvulsant: an in vitro comparative study in the 4-aminopyridine rat brain-slice model

G. Lees, C. Ganellin, A. Dougalis, 2004, Neuropharmacology.

The sleep inducing brain lipid cis-oleamide (cOA) does not modulate serotonergic transmission in the CA1 pyramidal neurons of the hippocampus in vitro

G. Lees, C. Ganellin, A. Dougalis, 2004, Neuropharmacology.

Differences in the actions of some blockers of the calcium‐activated potassium permeability in mammalian red cells

D. Jenkinson, C. Ganellin, C. Roxburgh, 1999, British journal of pharmacology.

Calcium-activated Potassium Channels Sustain Calcium Signaling in T Lymphocytes

Mark J. Miller, M. Miller, K. Chandy, 2001, The Journal of Biological Chemistry.

The pharmacology of cimetidine, a new histamine H2‐receptor antagonist

M. Parsons, G. Durant, C. Ganellin, 2010, British journal of pharmacology.

Selective blockers and manipulated channel expression levels

Mark J. Miller, M. Miller, M. Cahalan, 2001 .

Correlation between log POCT/H2O and pKB estimates for a series of muscarinic and histamine H2‐receptor antagonists

J. Black, R. Mitchell, N. Shankley, 1988, British journal of pharmacology.

Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties.

J. Schwartz, H. Stark, J. Arrang, 2002, Journal of medicinal chemistry.

The histamine H3 receptor and its ligands.

J. Schwartz, H. Stark, J. Arrang, 2001, Progress in medicinal chemistry.

Synthesis and pharmacological testing of polyaminoquinolines as blockers of the apamin-sensitive Ca2+-activated K+ channel (SKCa)

D. I. Fletcher, D. Jenkinson, C. Ganellin, 2007 .

Defining determinant molecular properties for the blockade of the apamin-sensitive SKCa channel in guinea-pig hepatocytes: the influence of polarizability and molecular geometry.

D. Galanakis, C. Ganellin, 2004, Bioorganic & medicinal chemistry letters.

Synthesis and quantitative structure-activity relationships of dequalinium analogues as K+ channel blockers: investigation into the role of the substituent at position 4 of the quinoline ring.

D. Galanakis, P. M. Dunn, J. A. Calder, 1995, Journal of medicinal chemistry.

Inhibition of the antigen-induced activation of RBL-2H3 cells by cetiedil and some of its analogues.

C. Ganellin, J. Narenjkar, E. Assem, 2004, European journal of pharmacology.

Imidazole derivatives as a novel class of hybrid compounds with inhibitory histamine N-methyltransferase potencies and histamine hH3 receptor affinities.

J. Schwartz, H. Stark, Yuan H. Zhao, 2003, Bioorganic & medicinal chemistry.

Synthesis and quantitative structure-activity relationship of a novel series of small conductance Ca(2+)-activated K+ channel blockers related to dequalinium.

C. Ganellin, D. Galanakis, P. M. Dunn, 1996, Journal of medicinal chemistry.

bis-Quinolinium cyclophanes: 8,14-diaza-1,7(1, 4)-diquinolinacyclotetradecaphane (UCL 1848), a highly potent and selective, nonpeptidic blocker of the apamin-sensitive Ca(2+)-activated K(+) channel.

D. Jenkinson, C. Ganellin, D. Galanakis, 2000, Journal of medicinal chemistry.

Bis-quinolinium cyclophanes: A novel class of potent blockers of the apamin-sensitive Ca2+-activated K+ channel

D. Jenkinson, C. Ganellin, D. Galanakis, 1997 .